The University of North Carolina at Chapel Hill
Skip to main content
UNC School of Medicine

Category: Pulmonary Diseases and Critical Care Medicine

  • Subhashini Sellers, MD

    Sellers Receives Pilot Funding To Study Upper Respiratory Immune Response in COVID-19

    Subhashini Sellers, MD Subhashini Sellers, MD, MSc, assistant professor in the division of pulmonary and critical care medicine, has received pilot funding from the UNC Center for Environmental Health Sciences to study the upper respiratory immune response in COVID-19. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and resulting Coronavirus disease 2019 (COVID-19) r … Read more

  • Richard Boucher-new-mask-newsweek-article

    Boucher Comments On the Quest For a COVID-19 Cure

    Richard Boucher, MD Richard Boucher, MD, the James C. Moeser Eminent Professor of Medicine, in the division of pulmonary diseases and critical care medicine, and director of the Marsico Lung Institute, explained to Gulf Today why he believes some repurposed drugs currently under consideration to treat COVID-19 patients could work. “The lung only fails in so many different ways, a … Read more

  • Richard Boucher-new-mask-newsweek-article

    Boucher Discusses Coronavirus Treatments With News & Observer

    Richard Boucher, MD While there is hope that a “sophisticated new drug treatment to prevent people from getting severely ill from COVID-19” will be available in the fall, experts says treatments most likely to be available with be repurposed therapeutic drugs meant to treat late-stage symptoms. Richard Boucher, MD, the James C. Moeser Eminent Professor of Medicine, Division of Pu … Read more

  • From H1N1 to COVID-19, Vigeland’s Career Focuses on Helping the Sickest

    Christine Vigeland, MD Christine Vigeland, MD, found her calling during residency as the H1N1 pandemic was ending in 2010. She dedicated her career to researching acute respiratory distress syndrome (ARDS) and treating ICU patients. Ten years later, the knowledge she’s gained and her continued commitment to the most critical patients are guiding her through another pandemic. “I d … Read more

  • June- Grants and Funding

    Department of Medicine Grants & Funding: June 1 – June 30, 2020

    Division of Cardiology Anil Gehi, MD, received a grant from the Bristol-Myers Squibb Foundation to create a new patient education program to help patients with atrial fibrillation during the COVID-19 pandemic. Division of Hematology Dougald Monroe, PhD, received NIH funding to help guide the development of novel treatments and new therapeutics for bleeding. Nigel Mackman, PhD, an … Read more

  • Hagan Receives ATS Junior Investigator Award

    Robert Hagan, MD, PhD Robert Hagan, MD, PhD, instructor in the division of pulmonary diseases and critical care medicine, has received a Junior Investigator Award from the American Thoracic Society’s Journal of Respiratory Cell and Molecular Biology. The prestigious award recognizes Hagan’s research on innate immunity in respiratory infections and lung injury and his paper Myeloi … Read more

  • shannon-carson

    Carson Says NC Is in the Midst of a Slower But Steady Surge of COVID-19 Cases

    Shannon Carson, MD A News & Observer article recognizes that the statewide stay-at-home order and other steps that have been take to keep people physically apart has worked to prevent a sharp spike in COVID-19 cases. However, the virus hasn’t gone away.  Shannon Carson, MD, chief of pulmonary diseases and critical care medicine says North Carolina is in the midst of a slower, … Read more

  • Richard Boucher-new-mask-newsweek-article

    Boucher Study Featured in Stars and Stripes

    Richard Boucher, MD Richard Boucher, MD, and the landmark study he co-authored was featured in Stars and Stripes, demonstrating why it’s important to wear a mask that covers the nose. Read the article here. Boucher is the James C. Moeser Eminent Professor of Medicine in the division of pulmonary diseases and critical care medicine.  

  • Richard Boucher-new-mask-newsweek-article

    Boucher Discusses Landmark Coronavirus Study With the News and Observer

    Richard Boucher, MD Richard Boucher, MD, the James C. Moeser Eminent Professor of Medicine in the division of pulmonary diseases and critical care medicine, talked with the News & Observer about the landmark study he co-authored, finding that the coronavirus infects the cells of in the nose much more easily than those in the throat and lungs. Read the article here.

  • wohl-fischer

    Wohl Says the Number of COVID Hospitalizations Provides Best Indication For How NC Is Flattening the Curve

    David Wohl, MD, and Billy Fischer, MD David Wohl, MD, professor of medicine in the division of infectious diseases and director of UNC Health’s Respiratory Diagnostic Center, told NC Health News that it could be several weeks before hospitals know the impact of the late May reopening and mass gatherings that have occurred since. Wohl believes focusing on hospitalizations rather t … Read more

  • Ric Boucher, MD

    Boucher Explains to US News & World Report How Coronavirus First Infects the Nose

    Ric Boucher, MD Richard Boucher, MD, discussed a major new scientific study that shows the coronavirus first infects the nasal passages, where cells have more of a protein that the virus needs to attach itself. “If the nose is the dominant initial site from which lung infections are seeded, then the widespread use of masks to protect the nasal passages, as well as any therapeutic … Read more

  • Richard Boucher-new-mask-newsweek-article

    Boucher, Baric Map SARS-CoV-2 Infection in Cells of Nasal Cavity, Bronchia, Lungs 

    Richard Boucher, MD In a major scientific study published in the journal Cell, scientists have characterized the specific ways in which SARS-CoV-2 – the coronavirus that causes COVID-19 – infects the nasal cavity to a great degree – replicating specific cell types – and infects and replicates progressively less well in cells lower down the respiratory tract, including the lungs. … Read more